Gabelli Funds’s Array Biopharma Inc ARRY Stock Holding History

Gabelli Funds’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-913,212	Closed	-$42.3M	–	1181
2019 Q2	$42.3M	Buy	+913,212	New	+$25.6M	0.27%	97

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Gabelli Funds's ARRY Position: Q3 2019 in Review

Gabelli Funds sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 913,212 shares — an estimated $42.3M sold.

Gabelli Funds first reported a position in ARRY in Q2 2019 and held it in 1 quarter. The position peaked at $42.3M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Gabelli Funds reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Gabelli Funds sold 913,212 Array Biopharma Inc shares in Q3 2019, an estimated $42.3M.
Gabelli Funds first reported a position in Array Biopharma Inc in Q2 2019 and held it in 1 quarter.
Gabelli Funds's Array Biopharma Inc position peaked at $42.3M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Gabelli Funds's 13F filing for Q3 2019, filed 1 Nov 2019.